EPHX2 Inhibits Colon Cancer Progression by Promoting Fatty Acid Degradation

EPHX2 Inhibits Colon Cancer Progression by Promoting Fatty Acid Degradation

Tumor cells use metabolic reprogramming to keep up with the need for bioenergy, biosynthesis, and oxidation balance needed for rapid tumor division. This phenomenon is considered a marker of tumors, including colon cancer (CRC). As an important pathway of cellular energy metabolism, fatty acid metab...

Full description

Bibliographic Details
Main Authors: Yiran Zhou, Xiao Li, Aoran Guan, Haodong Zhou, Yankun Zhu, Ruotian Wang, Ruhong Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Oncology
Subjects:
EPHX2
CRC
metabolic reprogramming
fatty acid degradation
ROS
lipid droplet
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.870721/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.870721/full

Similar Items